Nano4 awarded with P2020 Grant


Nano4 Global was awarded with a P2020 Grant for the scale-up of CoVID-19 Diagnostic System. This Grant will be instrumental for scale-up of a Diagnostic System for the molecular diagnostic of SARS-CoV-2.
Nano4 Global is a company, spin-off from FCT-Nova, established in 2015 and specialised on the development of Molecular Diagnostic Systems.
P2020 was set to bring together the five European Structural and Investment Funds - ERDF, Cohesion Fund, ESF, EAFRD and EMFF – setting the programming principles which enshrine the economic, social and territorial development policy to be advanced in Portugal, between 2014 and 2020.


News & Updates
  July  2021
NANO4 in partnership with CUF Hospitals and Clinics network initiates validation of diagnostics platform for Chronic Myeloid Leukaemia
  November  2019
NANO4 was recognized with the NOVA SPIN-OFF seal